Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.

导出 OA

翻译打印收藏纠错

第一作者： Yue,Liu

第一单位： Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

作者： Yue,Liu ^[1] ; Qian,Xiao ^[1] ; Jinjie,He ^[1] ; Hanguang,Hu ^[2] ; Jinlin,Du ^[3] ; Yuping,Zhu ^[4] ; Jiaqi,Chen ^[2] ; Zhuo,Liu ^[4] ; Jianping,Wang ^[3] ; Lifeng,Sun ^[1] ; Dong,Xu ^[1] ; Jun,Li ^[1] ; Xiujun,Liao ^[1] ; Jianwei,Wang ^[1] ; Yibo,Cai ^[4] ; Cheng,Cai ^[3] ; Zhekang,Jin ^[3] ; Liuhong,Wang ^[5] ; Ying,Yuan ^[2] ; Kefeng,Ding ^[6]

作者单位： Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. ^[1] Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. ^[2] Colorectal Surgery, Zhejiang University Jinhua Hospital, Jinhua, China. ^[3] Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China. ^[4] Radiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. ^[5] Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. dingkefeng@zju.edu.cn. ^[6] Cancer Center Zhejiang University, Zhejiang, China. dingkefeng@zju.edu.cn. ^[7]

关键词 Anlotinib Capecitabine First-line therapy Metastatic colorectal cancer Oxaliplatin